On Monday, South Africa began administering the new groundbreaking HIV prevention injection in the drugs first public rollouts in Africa, which has the worlds highest HIV burden.
Lenacapavir, which is a jab taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99,9, making it effective in the fight against HIV.
Neighbouring countries like Zambia and Eswatini received about 1 000 doses last month as part of a US programme and were also expected to launch the drug at World AIDS Day ceremonies on Monday.